| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kazuaki Takabe | |
| Kazuki Moro | |||
| Masayuki Nagahashi | |||
| Rajesh Ramanathan | |||
| Toshifumi Wakai | |||
| P2860 | cites work | Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 | Q24297600 |
| Endogenous HMGB1 regulates autophagy | Q24298865 | ||
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial | Q24607545 | ||
| Inflammation and cancer | Q24649640 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Inflammation and Alzheimer's disease | Q28138617 | ||
| Prostaglandins, bioassay and inflammation | Q28194428 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome | Q28387661 | ||
| A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense | Q28508815 | ||
| Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation | Q28716294 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Nonresolving inflammation | Q29616352 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Helicobacter pylori infection and the risk of gastric carcinoma | Q29618446 | ||
| Resolvin E1 and protectin D1 activate inflammation-resolution programmes | Q29618679 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| Pro-resolving lipid mediators are leads for resolution physiology | Q30829097 | ||
| Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis | Q33513370 | ||
| Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model | Q33781997 | ||
| Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase. | Q34067846 | ||
| Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation | Q34157528 | ||
| Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription. | Q34165938 | ||
| Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. | Q34251293 | ||
| Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation | Q34254403 | ||
| Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production | Q34546662 | ||
| Stem cells of the oesophageal epithelium | Q34603090 | ||
| Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease. | Q34779133 | ||
| Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation | Q34807449 | ||
| Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes | Q34955621 | ||
| Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models | Q34988809 | ||
| Resolution of inflammation: state of the art, definitions and terms | Q35058577 | ||
| Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection | Q35534073 | ||
| Bladder cancer and urinary Schistosomiasis in Angola. | Q35836214 | ||
| Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid | Q35879986 | ||
| ZEB1-responsive genes in non-small cell lung cancer | Q35915752 | ||
| Epidemiology of bladder cancer | Q35960975 | ||
| Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation | Q36076678 | ||
| Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. | Q36142593 | ||
| Impact of environmental and dietary factors on the course of inflammatory bowel disease | Q36144477 | ||
| Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing | Q36376065 | ||
| Fat-1 transgenic mice: a new model for omega-3 research | Q36397850 | ||
| Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 | ||
| Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Q36627430 | ||
| Dual acting anti-inflammatory drugs. | Q36737974 | ||
| Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis | Q36763871 | ||
| D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury | Q36860274 | ||
| Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. | Q36979196 | ||
| A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomize | Q37070847 | ||
| Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis | Q37122192 | ||
| Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 | ||
| Clinical approaches to non-alcoholic fatty liver disease | Q37596187 | ||
| Old and new generation lipid mediators in acute inflammation and resolution | Q37775277 | ||
| Lipid mediators in life science | Q37843189 | ||
| Mediator lipidomics in acute inflammation and resolution | Q38038152 | ||
| Lipid mediators of inflammation in obesity-related glomerulopathy | Q38148069 | ||
| Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers | Q38237483 | ||
| Pathogenesis of human papillomavirus-associated mucosal disease. | Q38325853 | ||
| A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer | Q38486007 | ||
| DNA damage response and sphingolipid signaling in liver diseases | Q38619642 | ||
| Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. | Q39080272 | ||
| Colorectal cancer risk in Crohn's disease | Q40112425 | ||
| Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential | Q40566710 | ||
| Fish, n - 3 polyunsaturated fatty acids and n - 6 polyunsaturated fatty acids intake and breast cancer risk: The Japan Public Health Center-based prospective study. | Q41610325 | ||
| Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease | Q42138710 | ||
| Esophageal malignancy: a growing concern | Q42394329 | ||
| Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. | Q42693504 | ||
| Cytomegalovirus-associated gastric ulcer: a side effect of steroid injections for pyloric stenosis | Q43240083 | ||
| Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway | Q44807764 | ||
| Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice | Q47907282 | ||
| [A case of primary carcinoma associated with anal fistula]. | Q53598259 | ||
| Fatty acid composition of the plasma lipids in Greenland Eskimos | Q55035434 | ||
| Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype | Q61575249 | ||
| Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages | Q61632775 | ||
| Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis | Q79369903 | ||
| Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial | Q82659698 | ||
| Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity | Q86617971 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 155-64 | |
| P577 | publication date | 2016-07-16 | |
| P1433 | published in | World journal of clinical cases | Q27725104 |
| P1476 | title | Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer | |
| P478 | volume | 4 |
| Q48174213 | Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models |
| Q47912313 | Dietary fatty acids modulation of human colon cancer cells: mechanisms and future perspectives |
| Q52624151 | Effects of Enteral Immunonutrition in Esophageal Cancer. |
| Q89716043 | Integrated transcriptomics, metabolomics, and lipidomics profiling in rat lung, blood, and serum for assessment of laser printer-emitted nanoparticle inhalation exposure-induced disease risks |
| Q37729599 | Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs |
| Q55514867 | Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System. |
| Q59133618 | The Lipid Mediator Resolvin D1 Reduces the Skin Inflammation and Oxidative Stress Induced by UV Irradiation in Hairless Mice |
| Q47704655 | The role of nutrition in influencing mechanisms involved in environmentally mediated diseases |
| Q57153732 | The role of sphingosine-1-phosphate in inflammation and cancer progression |
Search more.